Literature DB >> 9920468

Retrograde amnesia: clinical and methodological caveats.

N Kapur1, P Thompson, L D Kartsounis, P Abbott.   

Abstract

Several clinical and methodological caveats are outlined as they pertain to retrograde amnesia research, and data relevant to these caveats are presented. Three caveats in particular are noted in relation to recently published cases of marked retrograde amnesia; (i) temporal lobe epilepsy may influence memory for news events; (ii) there may be additional, unsuspected pathology in cases of amnesia, such as those with cerebral hypoxia; (iii) degree of media exposure is closely related to performance on the types of news events memory tests that are commonly used in retrograde amnesia research.

Entities:  

Mesh:

Year:  1999        PMID: 9920468     DOI: 10.1016/s0028-3932(98)00065-7

Source DB:  PubMed          Journal:  Neuropsychologia        ISSN: 0028-3932            Impact factor:   3.139


  5 in total

1.  The fate of old memories after medial temporal lobe damage.

Authors:  Peter J Bayley; Ramona O Hopkins; Larry R Squire
Journal:  J Neurosci       Date:  2006-12-20       Impact factor: 6.167

Review 2.  The neuroscience of remote memory.

Authors:  Larry R Squire; Peter J Bayley
Journal:  Curr Opin Neurobiol       Date:  2007-03-02       Impact factor: 6.627

3.  Episodic, but not semantic, autobiographical memory is reduced in amnestic mild cognitive impairment.

Authors:  Kelly J Murphy; Angela K Troyer; Brian Levine; Morris Moscovitch
Journal:  Neuropsychologia       Date:  2008-07-12       Impact factor: 3.139

Review 4.  Remote Memory in Epilepsy: Assessment, Impairment, and Implications Regarding Hippocampal Function.

Authors:  Sanya Rastogi; Kimford J Meador; William B Barr; Orrin Devinsky; Beth A Leeman-Markowski
Journal:  Front Neurol       Date:  2022-04-08       Impact factor: 4.086

5.  Recent innovative studies of memory in temporal lobe epilepsy.

Authors:  Brian D Bell; Anna R Giovagnoli
Journal:  Neuropsychol Rev       Date:  2007-11-17       Impact factor: 6.940

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.